1α-HYDROXY DERIVATIVES OF VITAMIN D3 AND RENAL FUNCTION
- 5 August 1978
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 312 (8084), 316-317
- https://doi.org/10.1016/s0140-6736(78)91719-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- REINTERPRETATION OF THE HÆMATOLOGICAL EFFECTS OF ANTICONVULSANT TREATMENTThe Lancet, 1978
- Preservation of Function in Experimental Renal Disease by Dietary Restriction of PhosphateNew England Journal of Medicine, 1978
- CORRELATION OF CLINICAL, BIOCHEMICAL AND SKELETAL RESPONSES TO l α -HYDROXYVITAMIN D3IN RENAL BONE DISEASEClinical Endocrinology, 1977
- Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.Archives of Disease in Childhood, 1977
- MONITORING PROGRESS OF CHRONIC RENAL FAILUREThe Lancet, 1977
- CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILUREThe Lancet, 1976
- Augmentation of Arterial Hepatic and Renal Flow by Extracted and Synthetic Parathyroid HormoneEndocrinology, 1974
- EFFECTS OF 1,25-DIHYDROXYCHOLECALCIFEROL ON CALCIUM ABSORPTION, MUSCLE WEAKNESS, AND BONE DISEASE IN CHRONIC RENAL FAILUREThe Lancet, 1974
- Changes in serum and urinary calcium during phosphate depletion: studies on mechanismsJCI Insight, 1970